Access our full library of guidance, white papers, and other resources developed by and for the medical technology industry.
In From Mechanical Precision to Software Intelligence, Kearney explores how MedTech companies can learn from the automotive industry’s shift to software-defined platforms. The article examines how connected devices, AI-enabled services,…
The State of Logistics 2026 report examines how structural volatility, geopolitical disruption, AI adoption, sustainability requirements, and shifting market dynamics are transforming global logistics. Kearney outlines the key trends shaping…
Explore AdvaMed’s Q2 2026 Report to see how advocacy, member engagement, and policy progress are advancing innovation and strengthening the medtech industry.
As the MedTech industry moves beyond insights-driven AI, Agentic AI is emerging as a transformative force for autonomous clinical decision-making and operational efficiency. This Everest Group whitepaper, supported by HCLTech,…
China GMP and ISO 13485: A Side-by-Side Comparison
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
AdvaMed’s feedback on the CEIVD draft outlines targeted recommendations to improve clarity in clinical evidence expectations for IVD devices, including more precise terminology, alignment with global frameworks, and clearer distinctions…
AdvaMed outlines recommendations to ensure EPA’s proposed ethylene oxide (EtO) emissions standards protect public health while maintaining access to life-saving medtech.
Explore AdvaMed®’s Q1 2026 report on medtech policy, regulatory trends, reimbursement, and advocacy driving innovation and patient access.
AdvaMed’s® comments on FDA’s 510(k) exemption framework for Class II devices and its impact on innovation and patient access.